[PDF] uj.edu.pl

[PDF][PDF] Practical aspects of new oral anticoagulant use in atrial fibrillation

A Undas, T Pasierski, J Windyga… - … = Polish Archives of …, 2014 - ruj.uj.edu.pl
Dabigatran, a direct thrombin inhibitor and 2 factor Xa inhibitors, rivaroxaban and apixaban,
are target‑‑specific oral anticoagulants (TSOACs) approved for prevention of stroke or …
被引用次数：52 相关文章

Practical aspects of new oral anticoagulant use in atrial fibrillation.

A Undas, T Pasierski, J Windyga… - Polskie Archiwum …, 2014 - europepmc.org
Dabigatran, a direct thrombin inhibitor and 2 factor Xa inhibitors, rivaroxaban and apixaban,
are target-specific oral anticoagulants (TSOACs) approved for prevention of stroke or …
[PDF] wum.edu.pl

[PDF][PDF] Practical aspects of new oral anticoagulant use in atrial fibrillation

A Undas, T Pasierski, J Windyga… - POLSKIE ARCHIWUM …, 2014 - ppm.wum.edu.pl
Dabigatran, a direct thrombin inhibitor and 2 factor Xa inhibitors, rivaroxaban and apixaban,
are target‑‑specific oral anticoagulants (TSOACs) approved for prevention of stroke or …
[PDF] ppm.edu.pl

[PDF][PDF] Practical aspects of new oral anticoagulant use in atrial fibrillation

A Undas, T Pasierski, J Windyga… - POLSKIE ARCHIWUM …, 2014 - ppm.edu.pl
Dabigatran, a direct thrombin inhibitor and 2 factor Xa inhibitors, rivaroxaban and apixaban,
are target‑‑specific oral anticoagulants (TSOACs) approved for prevention of stroke or …
[PDF] archive.org

[PDF][PDF] Practical aspects of new oral anticoagulant use in atrial fibrillation

A Undas, T Pasierski, J Windyga… - POLSKIE ARCHIWUM …, 2014 - scholar.archive.org
Dabigatran, a direct thrombin inhibitor and 2 factor Xa inhibitors, rivaroxaban and apixaban,
are target‑‑specific oral anticoagulants (TSOACs) approved for prevention of stroke or …

Practical aspects of new oral anticoagulant use in atrial fibrillation

A Undas, T Pasierski, J Windyga… - Polskie Archiwum …, 2014 - pubmed.ncbi.nlm.nih.gov
Dabigatran, a direct thrombin inhibitor and 2 factor Xa inhibitors, rivaroxaban and apixaban,
are target-specific oral anticoagulants (TSOACs) approved for prevention of stroke or …
[PDF] wum.edu.pl

[PDF][PDF] Practical aspects of new oral anticoagulant use in atrial fibrillation

A Undas, T Pasierski, J Windyga… - POLSKIE ARCHIWUM …, 2014 - ppm.wum.edu.pl
Dabigatran, a direct thrombin inhibitor and 2 factor Xa inhibitors, rivaroxaban and apixaban,
are target‑‑specific oral anticoagulants (TSOACs) approved for prevention of stroke or …